Skip to NavigationSkip to content


The FDA has approved Roche’s Rozlytrek (entrectinib) as a treatment for adults with ROS1-positive, metastatic non-small cell lung cancer (NSCLC).
Hundreds of people have turned to private clinics, in an effort to gain access to medicinal cannabis in the UK, according to the BBC.
Top 10 stories on this week!
Pfizer has recalled two lots of its migraine drug Relpax over concerns about microbiological contamination.
Regeneron is investing $800 million into its New York production facilities.
Regeneron has reported a strong showing for its investigational angiopoietin-like 3 (ANGPTL3) antibody evinacumab in the treatment of the rare...
Eli Lilly has unveiled new Phase 4 data supporting the efficacy and safety of Taltz when compared to Janssen’s Tremfya, showing that the former met...
The British Government is calling on logistics companies to bid for a £25 million contract to run express freight containers carrying daily...
The US FDA has approved BPaL, the TB Alliance’s treatment for drug-resistant tuberculosis (TB).
The AveXis executives that oversaw the marketing application for Zolgensma, the $2.1 million gene therapy at the centre of the faulty data scandal...
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches